Search Results - "Zaggia, Barbara"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Validation of the prognostic role of the “Helsinki Score” in 225 cases of adrenocortical carcinoma by Duregon, Eleonora, Cappellesso, Rocco, Maffeis, Valeria, Zaggia, Barbara, Ventura, Laura, Berruti, Alfredo, Terzolo, Massimo, Fassina, Ambrogio, Volante, Marco, Papotti, Mauro

    Published in Human pathology (01-04-2017)
    “…Adrenocortical carcinoma patient prognosis is extremely variable and poorly predictable. The newly introduced Helsinki Score is the first so far proposed…”
    Get full text
    Journal Article
  2. 2

    Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer by Porpiglia, Francesco, Fiori, Cristian, Daffara, Fulvia, Zaggia, Barbara, Bollito, Enrico, Volante, Marco, Berruti, Alfredo, Terzolo, Massimo

    Published in European urology (01-05-2010)
    “…Abstract Background Although there is consensus that laparoscopy is the standard of care for the resection of benign adrenal tumours, there is controversy…”
    Get full text
    Journal Article
  3. 3

    Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases by Duregon, Eleonora, MD, Volante, Marco, MD, PhD, Bollito, Enrico, MD, Goia, Margherita, MD, Buttigliero, Consuelo, MD, Zaggia, Barbara, MD, Berruti, Alfredo, MD, Scagliotti, Giorgio Vittorio, MD, Papotti, Mauro, MD

    Published in Human pathology (01-12-2015)
    “…Summary The correct pathologic classification of adrenocortical carcinoma (ACC) is relevant to establish an early therapeutic strategy of this rare malignancy…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly by Daffara, Fulvia, De Francia, Silvia, Reimondo, Giuseppe, Zaggia, Barbara, Aroasio, Emiliano, Porpiglia, Francesco, Volante, Marco, Termine, Angela, Di Carlo, Francesco, Dogliotti, Luigi, Angeli, Alberto, Berruti, Alfredo, Terzolo, Massimo

    Published in Endocrine-related cancer (01-12-2008)
    “…Toxicity of adjuvant mitotane treatment is poorly known; thus, our aim was to assess prospectively the unwanted effects of adjuvant mitotane treatment and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Practical treatment using mitotane for adrenocortical carcinoma by Terzolo, Massimo, Zaggia, Barbara, Allasino, Barbara, De Francia, Silvia

    “…Description of novel findings about the mechanism of action of mitotane and its activity as an adjunctive postoperative measure, or for treatment of advanced…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effects of mitotane on the hypothalamic–pituitary–adrenal axis in patients with adrenocortical carcinoma by Reimondo, Giuseppe, Puglisi, Soraya, Zaggia, Barbara, Basile, Vittoria, Saba, Laura, Perotti, Paola, De Francia, Silvia, Volante, Marco, Zatelli, Maria Chiara, Cannavò, Salvatore, Terzolo, Massimo

    Published in European journal of endocrinology (01-10-2017)
    “…Objective Mitotane, a drug used to treat adrenocortical cancer (ACC), inhibits multiple enzymatic steps of adrenocortical steroid biosynthesis, potentially…”
    Get full text
    Journal Article
  11. 11

    Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane by D’Avolio, Antonio, De Francia, Silvia, Basile, Vittoria, Cusato, Jessica, De Martino, Francesca, Pirro, Elisa, Piccione, Francesca, Ardito, Arianna, Zaggia, Barbara, Volante, Marco, Di Perri, Giovanni, Terzolo, Massimo

    Published in Pharmacogenetics and genomics (01-06-2013)
    “…OBJECTIVEThe aim of this study was to assess the potential impact of the pharmacogenetic variability of CYP2B6 and ABCB1 genes on the pharmacokinetics of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Diagnosi e terapia del carcinoma corticosurrenalico by Terzolo, Massimo, Zaggia, Barbara, Daffara, Fulvia, Ardito, Arianna, Basile, Vittoria, Ferrari, Laura, Berruti, Alfredo

    Published in L'Endocrinologo (01-02-2014)
    “…Sommario Il carcinoma corticosurrenalico (CCS) è un tumore raro e molto aggressivo. Al momento attuale non sono stati individuati approcci terapeutici…”
    Get full text
    Journal Article
  16. 16
  17. 17